TY - GEN 
AU - Parra-Izquierdo V
AU - Frías-Ordoñez J.S
AU - Cuadros C
AU - Vargas M
AU - Vera Chamorro J.F
AU - Romero Sanchez C
AU - Flórez-Sarmiento C.
PY - 2024
SN - 2105705
UR - http://hdl.handle.net/10818/61977
AB - Introduction: There are no studies on efficacy of tofacitinib for moderate-severe ulcerative colitis (UC) in pediatric patients in Latin America. The aim of this study was to describe the efficacy and safety, in real world, treated with tofacitinib in...
LA - eng
PB - Gastroenterologia y Hepatologia
KW - Disease management
KW - Inflammatory bowel diseases
KW - Janus kinase inhibitors
KW - Pediatrics
KW - Therapeutics
KW - Tofacitinib
KW - Ulcerative colitis
TI - Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombian pediatric patients: Real world experience [Tofacitinib en el tratamiento de la colitis ulcerosa moderada a grave en pacientes pediatricos colombianos: experiencia en mundo real]
DO - 10.1016/j.gastrohep.2023.09.013
ER -